NEOVASC INC (NVCN) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:NVCN • CA64065J4037

30.03 USD
+0.49 (+1.66%)
At close: Apr 10, 2023
29.425 USD
-0.61 (-2.01%)
Pre-Market: 4/11/2023, 8:55:46 AM
Fundamental Rating

1

NVCN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. NVCN may be in some trouble as it scores bad on both profitability and health. NVCN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NVCN had negative earnings in the past year.
  • NVCN had a negative operating cash flow in the past year.
NVCN Yearly Net Income VS EBIT VS OCF VS FCFNVCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M -100M

1.2 Ratios

  • NVCN has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NVCN Yearly ROA, ROE, ROICNVCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 500 -500 1K -1K

1.3 Margins

  • NVCN has a Gross Margin of 79.66%. This is amongst the best in the industry. NVCN outperforms 90.57% of its industry peers.
  • In the last couple of years the Gross Margin of NVCN has grown nicely.
  • NVCN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y17.59%
NVCN Yearly Profit, Operating, Gross MarginsNVCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -2K -4K -6K

3

2. Health

2.1 Basic Checks

  • NVCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NVCN has more shares outstanding
  • Compared to 1 year ago, NVCN has a worse debt to assets ratio.
NVCN Yearly Shares OutstandingNVCN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
NVCN Yearly Total Debt VS Total AssetsNVCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

  • NVCN has an Altman-Z score of -16.71. This is a bad value and indicates that NVCN is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -16.71, NVCN is not doing good in the industry: 87.26% of the companies in the same industry are doing better.
  • NVCN has a Debt/Equity ratio of 0.81. This is a neutral value indicating NVCN is somewhat dependend on debt financing.
  • The Debt to Equity ratio of NVCN (0.81) is worse than 75.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z -16.71
ROIC/WACCN/A
WACC9.15%
NVCN Yearly LT Debt VS Equity VS FCFNVCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M -100M

2.3 Liquidity

  • A Current Ratio of 2.96 indicates that NVCN has no problem at all paying its short term obligations.
  • The Current ratio of NVCN (2.96) is comparable to the rest of the industry.
  • NVCN has a Quick Ratio of 2.85. This indicates that NVCN is financially healthy and has no problem in meeting its short term obligations.
  • NVCN has a Quick ratio (2.85) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 2.85
NVCN Yearly Current Assets VS Current LiabilitesNVCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

  • NVCN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1143.35%.
  • The Revenue has grown by 49.47% in the past year. This is a very strong growth!
  • NVCN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.73% yearly.
EPS 1Y (TTM)-1143.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.5%
Revenue 1Y (TTM)49.47%
Revenue growth 3Y22.11%
Revenue growth 5Y-6.73%
Sales Q2Q%91.39%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NVCN Yearly Revenue VS EstimatesNVCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M
NVCN Yearly EPS VS EstimatesNVCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 -10K -20K -30K

0

4. Valuation

4.1 Price/Earnings Ratio

  • NVCN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVCN Price Earnings VS Forward Price EarningsNVCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVCN Per share dataNVCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • NVCN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEOVASC INC

NASDAQ:NVCN (4/10/2023, 8:00:02 PM)

Premarket: 29.425 -0.61 (-2.01%)

30.03

+0.49 (+1.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-23
Earnings (Next)05-10
Inst Owners14.64%
Inst Owner Change-24.47%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap82.70M
Revenue(TTM)3.81M
Net Income(TTM)-41.20M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.73
P/FCF N/A
P/OCF N/A
P/B 5.22
P/tB 5.22
EV/EBITDA N/A
EPS(TTM)-105.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-9.07
FCFYN/A
OCF(TTM)-9.05
OCFYN/A
SpS1.38
BVpS5.75
TBVpS5.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.66%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y17.59%
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.96
Quick Ratio 2.85
Altman-Z -16.71
F-Score3
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)28.29%
Cap/Depr(5y)34.48%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1143.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)49.47%
Revenue growth 3Y22.11%
Revenue growth 5Y-6.73%
Sales Q2Q%91.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.05%
OCF growth 3YN/A
OCF growth 5YN/A

NEOVASC INC / NVCN FAQ

What is the fundamental rating for NVCN stock?

ChartMill assigns a fundamental rating of 2 / 10 to NVCN.


Can you provide the valuation status for NEOVASC INC?

ChartMill assigns a valuation rating of 1 / 10 to NEOVASC INC (NVCN). This can be considered as Overvalued.


How profitable is NEOVASC INC (NVCN) stock?

NEOVASC INC (NVCN) has a profitability rating of 1 / 10.


What is the financial health of NEOVASC INC (NVCN) stock?

The financial health rating of NEOVASC INC (NVCN) is 3 / 10.